INNOVATE CORP
VATENYSETrading Snapshot
- Day Range
- $321.99 – $327.94
- 52-Week Range
- $3.75 – $21.30
- Volume
- $1.65B
- Avg Volume
- $2.01B
- Shares Outstanding
- 13.6M
- Next Earnings
- Oct 25, 2026
Fundamentals Snapshot
- Annual Revenue
- $1.34B
- Last Q Revenue
- $352M
- P/E Ratio
- —
- P/S Ratio
- 0.1x
- EPS (TTM)
- $-3.99
- Dividend Yield
- 2.28%
Why Investors Own VATE
- ✓High-growth profile — revenue up +20.8% YoY with expanding US Equity exposure.
- ✓Healthy economics — 27% gross margin and 9% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About INNOVATE CORP
A company profile for INNOVATE CORP isn’t available yet — check back soon.
Otter Score Breakdown
ⓘAnalyst Ratings
ⓘLatest News & Updates
Here are the top movers in Monday's session.
Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.
Keep an eye on the top gainers and losers in Monday's session.
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
There are notable gap-ups and gap-downs in today's session.
Traders are paying attention to the gapping stocks in Monday's session. Let's dive into which stocks are experiencing notable gaps.
12 Industrials Stocks Moving In Monday's Intraday Session
Gainers Bowman Consulting Group (NASDAQ:BWMN) stock increased by 55.7% to $42.39 during Monday's regular session. The market value of their outstanding shares is at $476.7 million. The company's, Q2 earnings
INNOVATE Files $100M Mixed Securities Shelf Registration Statement
https://www.sec.gov/Archives/edgar/data/1006837/000100683726000080/a2026forms-3registrationst.htm
Innovate Enters Open Market Sale Agreement With Jefferies To Sell Up To $31M Of Stock
In accordance with the terms of the Sales Agreement, under this prospectus supplement we may offer and sell shares of our common stock, par value $0.001 per share, having an aggregate offering price of up to $31 million